Core Insights - Astrana Health, Inc. will release its financial results for Q3 2025 on November 6, 2025, after market close [1] - A conference call to discuss these results is scheduled for 2:30 p.m. PT/5:30 p.m. ET on the same day [1][2] Company Overview - Astrana Health is a physician-centric, AI-powered healthcare company focused on delivering high-quality, patient-centered care [3] - The company supports over 20,000 providers and more than 1.6 million patients in value-based care arrangements [4] - Astrana aims to improve patient outcomes, enhance experiences, and support provider well-being through its scalable care delivery infrastructure and proprietary technology [3][4]

Core Viewpoint - Nutex Health Inc. is facing a class action securities lawsuit due to alleged securities fraud that occurred between August 8, 2024, and August 14, 2025 [2][3]. Group 1: Lawsuit Details - The lawsuit claims that Nutex Health Inc. made false statements and concealed information regarding its third-party vendor HaloMD, which allegedly engaged in fraudulent activities to defraud insurance companies [3]. - It is alleged that the revenues from Nutex's engagement with HaloMD were unsustainable due to the fraudulent nature of the conduct [3]. - The company is accused of overstating its remediation efforts regarding material weaknesses in its internal controls over financial reporting [3]. - Nutex reportedly failed to properly account for stock-based compensation obligations, misclassifying them as equity instead of liabilities [3]. - The lawsuit suggests that these issues increased the risk of Nutex being unable to file financial reports with the SEC in a timely manner [3]. - Overall, the lawsuit asserts that Nutex's business and financial prospects were overstated, leading to materially false and misleading public statements [3]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until October 21, 2025, to request to be appointed as lead plaintiff in the lawsuit [4]. - Participation in the lawsuit does not require any out-of-pocket costs or fees for class members [4]. Group 3: Legal Representation - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [5]. - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [5].